Psychoeducational intervention and prevention of relapse among schizophrenic disorders in the Italian community psychiatric network by Aguglia, Eugenio et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
Clinical Practice and Epidemiology 
in Mental Health
Open Access Research
Psychoeducational intervention and prevention of relapse among 
schizophrenic disorders in the Italian community psychiatric 
network
Eugenio Aguglia*1, Elisabetta Pascolo-Fabrici1, Francesca Bertossi1 and 
Mariano Bassi2
Address: 1Psychiatric Clinic of the University of Trieste, Via Paolo De Ralli 5, 34126, Trieste, Italy and 2Mental Health Department, Local Health 
Unit, AUSL Via Castiglione 29, 40124 Bologna, Italy
Email: Eugenio Aguglia* - e.aguglia@fmc.units.it; Elisabetta Pascolo-Fabrici - e.pascolo@fmc.units.it; 
Francesca Bertossi - bertossi.francesca@libero.it; Mariano Bassi - tarpon8349@libero.it
* Corresponding author    
Abstract
Background: The lack of compliance is associated with an increased risk of hospitalization and
switching or augmentation of therapy when compared with being compliant. A synergy of drug
therapy and psychosocial interventions can give more benefits in treatment.
Methods: A perspective study was conducted on 150 patients with schizophrenia over 15 centers
in Italy. The experimental group was treated with drug therapy, traditional psychosocial and
psychoeducation for the patients and their families, while the control group received traditional
psychosocial and drug intervention over 1 year.
Results: The experimental group showed a significant statistical improvement (p < 0,05) in almost
all the scales that have been assessed (BPRS, SAPS, SANS, SIMPSON-ANGUS SCALE,
LANCASHIRE QL SCALE). Significant was the reduction of the number of hospitalizations and of
days of hospital stay.
Conclusion:  As it is shown in international literature, psychoeducational intervention with
schizophrenic patients and their families can reduce the occurrence of relapse.
1. Background
The recent changes in the treatment of schizophrenic dis-
orders allow us to use both traditional and atypical antip-
sychotic drugs, and psychosocial interventions with a
reliable efficacy, in treating the symptoms of both positive
and negative schizophrenia [1-11].
The clear aim of the treatment of such disorders is not
only to control the symptoms, but it is also to prevent new
symptomatic acute phases, to bring the patient to comply
with the prescribed treatment plan, to restore a certain
social and working functioning and to reach a better qual-
ity of life.
Among the psychosocial interventions, the psychoeduca-
tional ones for the patients and their family, have been
considered to be the most promising and successful
within the last thirty years [12-14].
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The basic principles of the psychoeducational interven-
tions are represented by simple, correct and complete
information about the disorder and its possible treatment
methods [15].
The goal is also to try to make both the patients and their
family aware of those problems, which are related with
the disorder, the communication difficulties and the most
appropriate management of the stressors and life events.
All of these elements allow the patients and their family to
become more conscious and better able to deal with prob-
lems, fostering therefore an easier and more effective
course of the illness, especially when the psychoeduca-
tional interventions are associated with an appropriate
and long-term drug treatment [11,16].
A review of those studies published in this field since the
beginning of the 1980s, confirms that the use of psycho-
social treatments and combined with an appropriate long
term antipsychotic therapy, can reduce the percentage of
relapse [17] in a year to about 54%. If psychoeducational
interventions are carried out with patients and their fami-
lies [18], in addition to this assertive community
approach, the yearly relapses further decrease to 27% [19].
These psychoeducational interventions follow a cogni-
tive-behavioral model. This was probably one of the main
causes for the difficult and slow acceptance and popular-
ity of such new therapeutic interventions by the Italian
community mental health centers. In fact, still today,
despite their overwhelming success rate and their spread
among many psychiatric staffs in the world, the psychoed-
ucational approaches are still viewed with suspicion, and
many Italian psychiatrists are openly against them. The
open and latent fear is accepting therapeutic models
which appear to be too simple and limiting, oriented
more toward a biological approach of the disorder, which
is far from the Italian mental health community and tra-
dition. On the other hand, most of psychiatrist in Italy
have adopted a psychodynamic oriented approach,
though filtered through the requirements established by
social psychiatry and by the "setting" of the public psychi-
atric services after the Basaglia reform. Often, the idea of
introducing new treatment techniques with the most crit-
ical patients and their family members is viewed as an
attack to already consolidated effective procedures and to
rooted cultural models [20].
However, the total effectiveness of the psychoeducational
interventions cannot be disputed: in fact more than 20
researches around the world have demonstrated the effec-
tiveness and the encouraging cost-benefit relationship
[21-26] for a group of more than 1500 patients [27].
The positive effects of such psychoeducational interven-
tion on the patients and their family, are not only a
decrease of new symptomatic acute phases, but also a
decrease of the number of hospitalizations and a better
compliance with the treatment [27] especially the drug
one [1,29-33].
It is generally believed that people affected by schizophre-
nia that regularly take prescribed antipsychotic drugs,
show a faster and more complete remission, and a lower
risk of relapse [34].
Since the 1970s, many studies have confirmed that the
participation in a long term and stable drug treatment can
better prevent relapse compared to a more irregular and
discontinuous drug treatment. However, unfortunately,
only 50% of people affected by schizophrenia undergo
regular an adequate drug treatments for a set period of
time [35,36].
On the other hand it is generally agreed that not all
patients respond the same to drug treatments and that
those treatments do not show the same results with every
patient [37].
In many cases the benefits of such drug treatment are only
partial and therefore they are not very well liked by the
patients and by their families [38].
Several studies have shown that approximately one-third
of patients are fully compliant, one-third partially compli-
ant, and the final one third entirely non-compliant. [39-
41].
Another study demonstrated that 54,5% of patients were
compliant and that 39,0% were partially compliant. Par-
tial compliance was associated with an increased risk of
hospitalization and switching or augmentation of therapy
when compared with being compliant [42].
A decrease in compliance predicted an increase in PANSS
which corresponds to a worsening of symptoms [43].
A low compliance also predicts an increase risk of hospi-
talization: even small gaps in therapy (1–10 days)
increased the likelihood of hospitalization by twice,
whereas larger gaps in therapy (>30 days) increased the
likelihood of hospitalization by four times [43].
The psychoeducational interventions can facilitate schizo-
phrenic patients in gaining the necessary skills to effec-
tively manage a drug treatment.
In order to have the patient comply to an antipsychotic
drug treatment in a more appropriate way, it is necessaryClinical Practice and Epidemiology in Mental Health 2007, 3:7 http://www.cpementalhealth.com/content/3/1/7
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to: 1) assess thoroughly the patient's background in terms
of past drug therapies and of those factors which might
have prevented the compliance; 2) use, whenever it is pos-
sible, a "contractual" approach, in which any potential
change from its original layout can easily be discussed
with the patient; 3) educate the patients and the family
members on the disorder and its characteristics, and on
the prevention of potential relapses, making them aware
of the risks and the benefits of antipsychotic drugs; 4)
maintain, whenever it is possible, the control over those
patients who may temporarily neglect and/or refuse the
drug treatment, still offering them alternative solutions
[1,44].
Informative, short term psychoeducational interventions
seem to be not as effective in the long run, in maintaining
the compliance[28,45-47].
On the other hand, a more structured and prolonged psy-
choeducational treatment for patients and their families,
seem to be more effective in the long run [4,10,48-53].
2. Methods
2.1 Design of the study
This study was conducted in Italy, with the goal of trying
to identify the most effective tools in the prevention of
relapse among those affected by schizophrenia.
The main objective of the study was to assess the effective-
ness of the combination of a long term drug therapy and
a psychoeducational intervention, on people affected by
schizophrenia in reducing relapses in terms of number of
hospitalisations and clinical parameters.
The Italian protocol was developed based on the model of
a study conducted in Munich between 1990 and 1994, by
Kissling and Bauml, with a sample of 236 patients [1,54].
In this study, half of the patients affected by schizophrenia
underwent a traditional drug treatment (the control
group), while the second half of the sample underwent a
treatment, which included also, along with the traditional
psychosocial interventions, a psychoeducational treat-
ment. Traditional treatment together with psychoeduca-
tion was able to reduce of 45% the number of
hospitalization [1,54].
In Italy a an open, controlled multicentric research was
conducted in 15 Italian Community Mental Health Cent-
ers (Public Mental Health Departments and University
Psychiatric Clinics), for the duration of 1 year, excluding
the screening phases. In each CMHC, after each screening
phase, the patients were blindly randomized by the exper-
imenter into two groups. The control group (of a total of
66 people) was treated with a standard procedure (antip-
sychotic drug treatment and assertive community treat-
ment), while the study group (69 patients) received,
traditional psychosocial intervention, antipsychotic drug
treatment and a psychoeducational program. Such sam-
ple, comprised of patients and their families, participated
separately to 8 different parallel psychoeducational meet-
ings, of 60–90 minutes each. Such meetings were charac-
terized by an overlapping informative content, and were
run by two psychiatric operators (mainly by a psychiatrist
and a psychiatric nurse).
The scales assessment was carried out at the beginning of
the trial, after 6 months (T2), and 12 months (T4). At the
end of the study the parameters "Number of hospitaliza-
tions" and "Total number of hospital days" were checked.
Each time drug recording and vital parameters were
assessed. (Tab 1, Research protocol)
2.2 Patients
150 patients took part in this study. Their age ranged from
18 and 45 years. They were all diagnosed with schizophre-
nia, in agreement with the DSM IV (Diagnostic and Statis-
tical Manual of Mental Disorders, fourth edition) and the
ICD 10 (International Classification of Diseases, tenth
Table 1: Research protocol
Time T-x First screening phase
Time T 0 - Vital parameters
- Analysis of the drug treatment characteristics and Drug treatment 
registration
- Assessment scales administration
Time T 1 (After 3 months) - Vital parameters
Time T 2 (After 6 months) - Drug treatment registration
- Assessment scales administration
Time T 3 (After 9 months) - Vital parameters
Time T 4 (After 12 months) - Vital parameters
- Assessment scales administration
- Control for the re-hospitalization rate (Number of hospitalizations, 
Total number of hospital days)Clinical Practice and Epidemiology in Mental Health 2007, 3:7 http://www.cpementalhealth.com/content/3/1/7
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edition) and were undergoing a standardized therapy in
terms of types of drugs and dosages.
A set of criteria for the exclusion from the study included:
acute psychosis, a substance abuse problem, organic fac-
tors that could interfere with the clinical condition, the
patients' current participation in psychoeducational and
structured treatments, or their participation in the last two
years.
The analysis of the participants has shown no significant
clinical and socio-demographic differences between the
two groups. 135 patients finished the study; 15 dropped
out for different reasons unrelated to the study.
2.3 Antipsychotic drug treatment
Both groups followed the antipsychotic drug treatment
using traditional and atypical antipsychotic drugs, admin-
istered alone or combined. The current dosage was moni-
tored every 6 months, from the beginning of the study. An
equal percentage of patients in both the control and the
study groups, received also, during the study, some depot
or "long acting" (haloperidol decanoate, fluphenazine
decanoate, zuclopentixol decanoate) anti-psychotic
drugs.
2.4 Psychiatric assessment Scales
The following scales were administered during the study:
BPRS (Brief Psychiatric Rating Scale), SAPS (Scale for
Assessment of Positive Symptoms), SANS (Scale for
Assessment of Negative Symptoms), Sympson and Angus
Scale, ROMI (Rating of Medication Influences) and the
Lancaster QL (Lancaster Quality of Life Profile).
2.5 Psychoeducational program
The standardized psychoeducational program, managed
through an interactive educational method, took place in
8 sessions, in which the following topics were covered:
1. Introduction
2. What is schizophrenia?
3. What causes schizophrenia?
4. How to treat schizophrenia?
5. Psychosocial treatment strategies
6. Preventing relapses
7. The role of the family
8. Conclusion
2.6 Statistical methods
All of the data was elaborated and statistically measured
using the SAS procedure v 6.12. The basal homogeneity of
the groups was measured for both the demographic char-
acteristics and the measuring scales, using the Wilcoxon's
non-parametric test.
The measurement within treatments was conducted tak-
ing in consideration the starting and ending time of the
treatment: the significance of the difference was measured
using the Sign Rank Test.
The treatments were compared using an ANOVA model,
in which the fixed effects were the treatment and the cent-
ers; the assessment of the differences was done on the LS
means (means calculated with the least squares' method)
using the LSD test of the PRCO GLM.
2.7 Consent
The study was approved by the ethical committee and the
patient gave written informed consent.
3. Results
3.1 Socio demographic and clinical parameters
The two subgroups of subjects participating in the test
have the same clinical and socio-demographic characteris-
tics. The percentage of male vs female and the age groups
stratification in both groups appears to be similar, and the
differences are not of statistical significance. (Fig 1, Age ;
Fig 2, Sex)
Heart rate, blood pressure and body weight measure-
ments have remained the same during the entire treat-
ment program. (Tab. 2, Vital parameters)
Diagnosis according to the DSM IV has brought to a fur-
ther subdivision of the different subtypes of schizophre-
nia, the main one being the paranoid type, respectively
Age Figure 1
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40% in the study group and 43% in the control group
(difference n.s.). (Tab. 3, Diagnosis)
Time from the first diagnosis, the years of treatment, the
number of hospitalizations, and the current psychophar-
macological treatment, were also kept under considera-
tion.
All of the parameters have resulted substantially homoge-
neous and there was no substantial statistical significance
between the two study groups. (Tab. 4, Clinical parame-
ters: years from the diagnosis, years of treatment, number
of hospitalizations)
3.2 Assessment Scales
The BPRS showed a decrease in the gravity of symptoms
for both groups, but while the control group varied from
a basic score of 58.27 to a score of 47.45 after 12 months
with an improvement of 10.82 points (p < 0.05). The
study group showed a score of 56.77 at T0 and of 40.23 at
T4 with 16.54 points of difference (p < 0.05). The differ-
ence between the groups was statistically significant in
favor to the study group. (p < 0.05). (Fig. 3, BPRS scale)
The detailed analysis of the single items of the BPRS scale,
allows to highlight the items that changed most. The study
group has shown a better improvement (p < 0.05) in
delayed
emotional flattening, anxiety, emotional withdrawal, dis-
tractibility, thought disorganization, lack of collabora-
tion, artificial attitude. The motor skill and the excitability
items decreased equally in both groups (p > 0.05) (Tab. 5,
BPRS scale: assessment of item "emotion").
The study group had a significant improvement (p < 0.05)
in items of the BPRS Behaviour subscale such as: depres-
sion, personal neglect, somatic preoccupation, and unu-
sual thought process. (Tab. 6, BPRS scale: assessment of
item: "behavior")
SAPS Scale was used to asses positive symptoms (halluci-
nations, delusions, strange behavior, thought disorder).
The total score has shown a statistical significant decrease
for both groups. The study group changed from 47.2 to
32.57 points with a difference of 15.7 points (<0.05); the
control group varied from 48.46 to 41.71 points with a
6.75 point difference. A highly significant difference was
found between the two groups (<0.001). (Fig. 4, SAPS
scale)
A reduction in the delusional symptoms has contributed
to a significant difference of 8.19 points compared with
4.74 points for the control group (p < 0.01). (Fig. 5, SAPS
scale, group of items)
The analysis of the changes in the negative symptoms was
conducted using the SANS Scale. The study group showed
an improvement of 9.9 points (from 56.63, to 46.73
Table 2: Vital parameters
(p > 0.05) VITAL PARAMETERS T0 T1 T2 T3 T4
Heart rate (Beats/min)
STUDY 81,92 80,58 81,80 80,55 80,97
CONTROL 79,92 78,82 80,02 80,64 82,16
Systolic pressure (mmHg)
STUDY 119,90 118,72 120,43 121,97 121,50
CONTROL 121,35 120,54 121,91 120,33 122,97
Diastolic pressure (mmHg)
STUDY 75,73 75,09 75,33 75,97 76,33
CONTROL 75,63 75,74 75,53 74,66 77,33
Body weight (Kg)
STUDY 76,04 76,52 76,78 77,26 75,90
CONTROL 76,98 77,70 76,63 78,01 79,65
Sex Figure 2
Sex.Clinical Practice and Epidemiology in Mental Health 2007, 3:7 http://www.cpementalhealth.com/content/3/1/7
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points, p < 0.05) while the control group had and
improvement of only 0.66 points, going from 52.8 to
51.52. (n.s). The difference between the groups had statis-
tical significance (p < 0.05) (Fig. 6, SANS scale).
The study group showed a significant difference in the
item distraction, showing a change of 1.62 points com-
pared to the 0.81 points of change for the control group
(p < 0.05). As for the other parameters, the study group
scored better improvements, but the difference between
the groups was non significant (p > 0.05). (Fig 7, SANS
scale, group of items)
The ROMI Scale measures the reasons for participating or
not in a treatment program and was assessed by both the
patients and the research physicians.
The subset "Reasons for good participating to the treat-
ment", showed no difference between the groups (p >
0.05). (Fig 8, ROMI scale: reasons for participating)
The subset "Reasons for non participating to the treat-
ment" such as bad relationship between the doctor and
the patient, bad relationship with the psychiatric staff,
denial about the disease, need for current treatment,
desire for hospitalization, interference with personal
activities, refusal to take medications, were improved in
the control group with and increase of 0.08 points com-
pared to a decrease of 1.8 points for the study group (p <
0.05). (Fig 9, ROMI scale: reasons for non participating)
The Simpson-Angus Scale measures the assessment of the
extrapyramidal effects. Though the different treatments
were comparable between the two groups, the study
group showed a decrease of 1.36 points compared with
0.97 points for the control group but the difference was
non significant.(p > 0.05). (Fig. 10, Simpson-Angus scale)
The quality of life at the Lancashire QL scale demonstrated
ad increase for the study group of 9.52 points (from
100,85 points, to 110,37 points), and an improvement
for the control group of 0.33 points for the total scale (p <
0.05); in particular regard to the items wellness, work, lei-
sure, religion, economic situation, family relationship,
social relationship, overall wellbeing (p < 0.05). (Fig 11,
Lancashire QL scale)
The percentage of the subjects hospitalized between 1 and
3 times during the 12 months resulted to be 13% after 6
months, and 3,3% after a year with a difference of 9.7%
for the study group; while for the control group the varia-
tion went from 17.7% at 6 months to 10.5% after 1 year
with an improvement of 7,2%. The difference between
Table 4: Clinical parameters: years from the diagnosis, years of treatment, number of hospitalizations
Clinical parameters Duration STUDY (%) CONTROL (%)
Number of years from the diagnosis of schizophrenia Less than 1 year 2 4
From 1 to 5 years 31 55
From 6 to 10 years 37 19
Over 10 years 30 22
Number of years of treatment Less than l year 5 5
From 1 to 5 years 36 56
From 6 to 10 years 34 19
Over 10 years 25 20
Number of hospitalizations in the last three years None 28 26
From 1 to 3 48 47
From 4 to 6 18 19
From 7 to 10 2 6
Over 10 4 2
Table 3: Diagnosis
DIAGNOSIS
STUDY (%) CONTROL (%)
Schizophrenia 15 17
Disorganized Schizophrenia 9 23
Paranoid Schizophrenia 40 43
Catatonic Schizophrenia 2 0
Non-differentiated Schizophrenia 19 13
Residual Schizophrenia 15 4Clinical Practice and Epidemiology in Mental Health 2007, 3:7 http://www.cpementalhealth.com/content/3/1/7
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groups showed statistical significance (p < 0.05). (Fig. 12,
Number of Hospitalizations)
There was also a decrease of mean number of days of hos-
pital stays for each hospitalisationfor the study group (42
days) compared to the control group (53 days); (p <
0.05). (Fig. 13, Number of days of hospital stays)
4. Discussion
4.1 Findings
The experimental group showed a significant statistical
improvement (p < 0,05) in almost all the scales that have
been assessed (BPRS, SAPS, SANS, SIMPSON-ANGUS
SCALE, LANCASHIRE QL SCALE). Significant was the
reduction of relapse in terms of numbers of hospitaliza-
tion, days of hospital stay and clinical parameters. This
was the main objective of our study and was significantly
confirmed in the effect of the overall improvent on most
clinical parameters, quality of life, relation with the staff.
The different changing in BPRS over the time can suggest
the role of psychoeducation in the improvement of clini-
cal parameters. Both groups showed a decrease of gravity
of the symptoms in the first 4 months, this can be due to
the consolidated synergy between drug treatment and
standard psychosocial intervention. The study group
keeps on improving over the 12 months of the study and
this can be related to the capacity of psychoeducation to
help in handling with the symptoms, have a better thera-
peutic alliance and prevent the relapse of the psychosis.
The analysis of BPRS can show how much psychoeduca-
tion can help in reduce certain symptoms as emotional
flattening, anxiety, emotional withdrawal, distractibility,
thought disorganization, lack of collaboration, artificial
attitude, but especially we found a particular improve-
ment in depression, personal neglect, somatic preoccupa-
tion, and unusual thought process.
To a less extent psychoeducation can improve anxiety,
confusion, hallucinations, strange behavior, over excite-
ment, grandiose feelings, hostility, suicidal tendencies. As
for the suspicion item, the difference was identical for
both groups: a more specific treatment can be required to
improve this item.
The changing in both positive and negative symptoms
measured by SAPS and SANS scales evidences how psych-
oeducation can give a generalized improvement over all
kind of symptoms.
The changes in ROMI scale highlighted the importance of
psychoeducation as shown by the improvement of the
relationship with the staff, the increase of awareness of the
Table 5: BPRS scale: assessment of item "emotion"
THE BPRS SCALE Assessment of each item: EMOTION
GROUP CONTOL
T0 T4 Diff.T 0 T 4 Diff,
Thought disorganization 2,56 2,00 -0,56 2,34 2,18 -0,16
Emotional flattening 3,24 2,24 -7,00 2,80 2,61 -0,79
Emotional withdrawal 3,37 2,34 -7,03 3,18 2,80 -0,38
Delayed motor skills 2,53 1,42 -1,11 2,13 1,85 -0,28
Tension 3,48 2,16 -1.32 3,10 2,55 -0,55
Lack of compliance 2,11 1,29 -0,82 1,98 1,56 -0,42
Excitement 1,63 1,11 -0,52 1,99 1,44 -0,55
Distractibility 2,38 1,40 -0.98 2,30 1,80 -0,50
Motor skill hyperactivity 1,59 1,06 -0,53 1,76 1,32 -0,44
Artificial behavior 1,89 1,24 -0,65 1,92 1,67 -0,25
TOTAL Assessment 24,80 16,27 -8,53 23,47 19,77 -3,70
BPRS scale Figure 3
BPRS scale.Clinical Practice and Epidemiology in Mental Health 2007, 3:7 http://www.cpementalhealth.com/content/3/1/7
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illness and the needing for treatment, the positive believe
of the family, the prevention of relapse and the improve-
ment of compliance. The psychoeducational approach
has helped family members to live with patients and their
disorder, and, at the same time, it has highlighted the
more positive qualities of patients.
The lack of significant difference in the extrapiramidal
effect (Simpson-Angus scale) can be explained with the
consideration the this parameter is due to the pharmaco-
therapy and it is not significantly influenced by psychoed-
ucation, though the difference registered between the two
groups can show that psychoeducation can teach the
patient and the family to recognize earlier the side effects
and relate to the doctor for changing the drug treatment.
The study group has shown an important and persistent
improvement in the quality of life (Lancashire scale),
while the other group had not improved over the year of
SAPS scale, group of items Figure 5
SAPS scale, group of items.
Table 6: BPRS scale: assessment of item: "behaviour"
BPRS SCALE Assessment of each item: BEHAVIOUR
GROUP CONTROL
T0 T4 Diff,T 0 T 4 Diff.
Somatic 
preoccupation
3,23 2,08 -1,15 2,77 2,23 -0,54
Anxiety 3,59 2,40 -1,19 3,25 2,47 -0,78
Depression 2,71 1,53 -1,18 2,52 2,08 -0,44
Suicidal tendencies 1,01 0,85 -0.16 1,11 1,03 -0,08
Feelings of guilt 2,03 1,21 -0,82 1,71 1,60 -0,11
Hostility 2,17 1,32 -0,85 2,48 1,73 -0,75
Over excitement 1,61 1.06 -0,55 1,76 1,36 -0,40
Grandiosity 1,99 1,26 -0,73 2,18 1,59 -0,59
Suspicious 
behavior
2,94 1,76 -0,18 3,67 2,48 -0,19
Hallucinations 2,50 1,58 -0,92 2,55 1,91 -0,64
Unusual thought 
process
3,59 2,27 -1,32 3.23 2,45 -0,78
Strange behavior 2,50 1,71 -0,79 2,72 2,08 -0,64
Personal neglect 2,48 1,53 -0,95 2,32 2,09 -0,23
Disorientation 1,47 1,00 -0,47 1,13 1,27 0,74
TOTAL 
Assessment
33,82 21,56 -12,26 33,26 26,24 -7,02
SAPS scale Figure 4
SAPS scale.Clinical Practice and Epidemiology in Mental Health 2007, 3:7 http://www.cpementalhealth.com/content/3/1/7
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the study: this difference in due to the overall benefits of
psychoeducation that lead to a better adherence to the
whole program.
The number of psychoeducational sessions was only 8
and we suggest this program could be further improved in
terms of number of sessions, items of discussions, role of
the family and the patients in the process in order to better
maintain the positive outcomes and the parameters that
have not improved.
4.3 Methodological issues
This study has some limitations. It is a cross-sectional
study and cohort effect can distort the results. The number
of the patients in small, so larger studies is needed to con-
firm this data. This bias could be reduced comparing the
data with an international meta-analysis.
Though the staff carrying out psychoeducation and stand-
ard psychosocial intervention and the staff administering
the scales were different, the open label design of the
study could bring some biases. A double blind study
should be recommended.
This study has several strengths. It evaluates the efficacy of
psychoeducation in the real clinical practice following a
multicenter design and it analyses not only the clinical
parameters, the relationship and the quality of life as dif-
ferent parameters, but it also focuses on how the improve-
ment of compliance can lead to a reduction of relapse, as
it is shown in international literature.
5. Conclusion
A number of studies have show that a psychoeducational
intervention with schizophrenic patients and their fami-
lies, could reduce the occurrence of relapse [2,55-58].
Such decrease seems to be related with a decrease in hos-
pitalizations, with less sick days on the job, and with less
social expenses [59-61].
ROMI scale: reasons for non participating Figure 9
ROMI scale: reasons for non participating.
SANS scale, group of items Figure 7
SANS scale, group of items.
SANS scale Figure 6
SANS scale.
ROMI scale: reasons for participating Figure 8
ROMI scale: reasons for participating.Clinical Practice and Epidemiology in Mental Health 2007, 3:7 http://www.cpementalhealth.com/content/3/1/7
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The study is part of an international program whose effort
is to assess the effectiveness of a psychoeducational treat-
ment in the prevention of relapses, through a change in
the understanding and the acceptance of the disorder. Our
study confirms improvements on most clinical parame-
ters, quality of life, adherence to the treatment program,
reduction of relapse and number of hospitalisation.
A psychoeducational therapeutic approach always seems
to have positive effects on both the patients and their fam-
ily. In fact, results show that even short term educational-
informative contents were able to improve the patients'
level of compliance to the treatment program, the
patients' and their family members' attitude toward the
disorder, and their attitude toward the psychiatric staff.
Also, such educational approach seem to be able to
improve the individuals' perception of quality of life,
which represents an indirect tool used to reduce self and
hetero-stigmatization. The participation of family mem-
bers in the study has allowed a more effective manage-
ment of the patient and a better implementation of a
psychosocial rehabilitation process.
In addition to the unquestionable advantages of such
integrative treatment plan, there is also a decrease in costs
associated with hospitalizations, loss of working days,
tension, family and social apprehensions.
In conclusion, such multicentric experience allows us to
confirm that the psychoeducational approach has con-
tributed significantly to an integrated approach that put
together patients active role in managing symptoms, fam-
ily members participation and psychiatric staff work that
led to a global improvement and a reduction of relapses
and hospitalizations.
The result is an undoubtedly great advantage for the
patients, who becomes an active participant in their ther-
apeutic process, experiencing not only an improvement
from a clinical stand point, but also an overall increased
psychological wellness, reducing significantly the troubles
and the bad feelings caused by such afflicting disorder.
Number of days of hospital stays Figure 13
Number of days of hospital stays.
Lancashire QL scale Figure 11
Lancashire QL scale.
Simpson-Angus scale Figure 10
Simpson-Angus scale.
Number of Hospitalizations Figure 12
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